DE3882982D1 - Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel. - Google Patents

Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel.

Info

Publication number
DE3882982D1
DE3882982D1 DE8888909359T DE3882982T DE3882982D1 DE 3882982 D1 DE3882982 D1 DE 3882982D1 DE 8888909359 T DE8888909359 T DE 8888909359T DE 3882982 T DE3882982 T DE 3882982T DE 3882982 D1 DE3882982 D1 DE 3882982D1
Authority
DE
Germany
Prior art keywords
different
same
action
leucocytes
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888909359T
Other languages
English (en)
Other versions
DE3882982T2 (de
Inventor
Toru Nakao
Minoru Kawakami
Masao Hisadome
Tetsuya Tahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of DE3882982D1 publication Critical patent/DE3882982D1/de
Application granted granted Critical
Publication of DE3882982T2 publication Critical patent/DE3882982T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36—Benzo-cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE88909359T 1987-11-02 1988-10-29 Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel. Expired - Fee Related DE3882982T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27809987 1987-11-02
JP24829588 1988-09-30

Publications (2)

Publication Number Publication Date
DE3882982D1 true DE3882982D1 (de) 1993-09-09
DE3882982T2 DE3882982T2 (de) 1993-11-25

Family

ID=26538701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88909359T Expired - Fee Related DE3882982T2 (de) 1987-11-02 1988-10-29 Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel.

Country Status (6)

Country Link
US (1) US5045541A (de)
EP (1) EP0351435B1 (de)
JP (1) JP2623784B2 (de)
AT (1) ATE92476T1 (de)
DE (1) DE3882982T2 (de)
WO (1) WO1989004306A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5339890A (en) * 1993-02-08 1994-08-23 Climate Master, Inc. Ground source heat pump system comprising modular subterranean heat exchange units with concentric conduits
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
GB9610893D0 (en) * 1996-05-24 1996-07-31 Astra Pharma Prod Pharmaceutically useful compounds
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
JP2001501180A (ja) * 1996-09-05 2001-01-30 アストラ・フアーマシユウテイカルズ・リミテツド 新規なアリールピリダジン
EP1430033A4 (de) 2001-08-31 2004-12-15 Univ Northwestern Entzündunshemmende und proteinkinaseinhibierende zusammensetzung und deren verwendung
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
MX2007005247A (es) 2004-11-02 2008-03-13 Univ Northwestern Compuestos de piridazina, composiciones y metodos.
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
AU2007243280A1 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
EP2015751A2 (de) * 2006-04-28 2009-01-21 Northwestern University Salze aus pyridazinverbindungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602019A (en) * 1983-04-22 1986-07-22 Warner-Lambert Company Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents
GB2164643B (en) * 1984-07-27 1988-11-02 Boehringer Biochemia Srl Tricyclic dihydropyridazinones and pharmaceutical compositions containing them
JPH06763B2 (ja) * 1984-08-28 1994-01-05 吉富製薬株式会社 ベンゾ〔ｈ〕シンノリン誘導体
AU578496B2 (en) * 1984-11-01 1988-10-27 Smith Kline & French Laboratories Limited Tricyclic heterocyclic compounds
JPH0633277B2 (ja) * 1986-01-10 1994-05-02 吉富製薬株式会社 ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物
ES2038708T3 (es) * 1987-03-02 1996-07-16 Yoshitomi Pharmaceutical Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
JP2531687B2 (ja) * 1987-07-01 1996-09-04 吉富製薬株式会社 ベンズオキセピノ〔５，４−ｃ〕ピリダジン化合物
JPH06147468A (ja) * 1992-11-16 1994-05-27 Sanden Corp 気化式燃焼装置の制御方法
JPH06156169A (ja) * 1992-11-18 1994-06-03 Mitsubishi Motors Corp キャブオーバトラックのフロントグリル

Also Published As

Publication number Publication date
JP2623784B2 (ja) 1997-06-25
EP0351435A1 (de) 1990-01-24
US5045541A (en) 1991-09-03
ATE92476T1 (de) 1993-08-15
EP0351435A4 (de) 1990-02-26
EP0351435B1 (de) 1993-08-04
DE3882982T2 (de) 1993-11-25
JPH02167269A (ja) 1990-06-27
WO1989004306A1 (en) 1989-05-18

Similar Documents

Publication Publication Date Title
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
ATE63742T1 (de) Chinazolinon-derivate.
ES8801651A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
FR2384773A1 (fr) Nouveaux composes heterocycliques a activite spasmolytique
DE3882982D1 (de) Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel.
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
DK521685D0 (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
ATE56713T1 (de) 1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
FI864003A (fi) Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar.
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
ATE42098T1 (de) 1,2,4-thiadiazine und ihre salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und sie enthaltende arzneimittel.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
EP0204003A4 (de) 2-(1-piperazinyl)-4-substituierte phenylchinolin-abkömmlinge.
ES8304956A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ATE57185T1 (de) Pyrido(1,2-a>pyrimidinderivate.
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
AU2059688A (en) Chloroaniline derivatives
DE3853895D1 (de) Substituierte 9-Amino-spiro[cycloalkyl[b]chinolin-2,1'cycloalkane], Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee